Skip to main content
Clinical Trials/CTRI/2023/03/051225
CTRI/2023/03/051225
Completed
未知

A retrospective, electronic health records study of patients prescribed with Evion® LC. - EROS

Procter & Gamble Health Limited (PGHL)0 sites1,626 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Procter & Gamble Health Limited (PGHL)
Enrollment
1626
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 30, 2023
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
Procter & Gamble Health Limited (PGHL)

Eligibility Criteria

Inclusion Criteria

  • Electronic medical records (EMR) of male or female adult patients 18 years and above of age, who were prescribed Evion® LC, will be selected.

Exclusion Criteria

  • EMR with any incomplete key data points will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials